American Journal of Cardiology
Volume 101, Issue 9 , Pages 1281-1284, 1 May 2008

Prevalence of Metabolic Syndrome in Retired National Football League Players

  • Marc A. Miller, MD

      Affiliations

    • The Zena and Michael A. Wiener Cardiovascular Institute, Mount Sinai Medical Center, New York, New York
    • Corresponding Author InformationCorresponding author: Tel: 212-241-6500; fax: 212-426-6376.
  • ,
  • Lori B. Croft, MD

      Affiliations

    • The Zena and Michael A. Wiener Cardiovascular Institute, Mount Sinai Medical Center, New York, New York
  • ,
  • Adam R. Belanger, BA

      Affiliations

    • The Zena and Michael A. Wiener Cardiovascular Institute, Mount Sinai Medical Center, New York, New York
  • ,
  • Abel Romero-Corral, MD

      Affiliations

    • Division of Cardiovascular Diseases, Department of Internal Medicine, Mayo Clinic and Foundation, Rochester, Minnesota
  • ,
  • Virend K. Somers, MD, PhD

      Affiliations

    • Division of Cardiovascular Diseases, Department of Internal Medicine, Mayo Clinic and Foundation, Rochester, Minnesota
  • ,
  • Arthur J. Roberts, MD

      Affiliations

    • Living Heart Foundation, Little Silver, New Jersey.
  • ,
  • Martin E. Goldman, MD

      Affiliations

    • The Zena and Michael A. Wiener Cardiovascular Institute, Mount Sinai Medical Center, New York, New York

Received 18 November 2007; received in revised form 19 December 2007; accepted 19 December 2007. published online 04 March 2008.

The National Institute of Occupational Safety and Health mortality study of National Football League (NFL) players concluded that retired NFL linemen have an increased risk of cardiovascular death compared with both nonlinemen and the general population. Though elevated body mass index contributed to the increased cardiac risk of linemen, it could not fully account for the mortality observed, suggesting that other unmeasured cardiovascular risk factors were involved. We performed a cross-sectional prevalence study of metabolic syndrome (MS), and its individual component criteria, in 510 retired NFL players who were recruited to multicity health screenings from February 2004 through June 2006. The International Diabetes Federation criteria were used to define MS. The MS component criteria of body mass index >30 kg/m2, reduced high-density lipoprotein, and raised fasting glucose were more prevalent in linemen compared with nonlinemen (85.4% vs 50.3%, p <0.001; 42.1% vs 32.7%, p = 0.04; 60.4% vs 37.6%, p <0.001, respectively). Metabolic syndrome was more prevalent in linemen compared with nonlinemen (59.8% vs 30.1%, p <0.001). In conclusion, linemen exhibited a high prevalence of MS, almost double the prevalence of their nonlinemen counterparts. These findings may partially explain the increased risk for cardiovascular death observed in retired linemen and could have significant public health implications for preprofessional training regimens and postprofessional health maintenance.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Dr. Belanger was supported by a generous grant from the Doris Duke Clinical Research Foundation, New York, New York. Dr. Somers is a consultant to Respironics, ResMed, Cardiac Concepts Inc. and Sepracor. Dr. Roberts (The Living Heart Foundation) has received funding from Phillips, Siemens, Pfizer, General Electric, ResMed and the Professional Athletes Trust Fund. The companies and organizations providing funding support to the Living Heart Foundation had no role in the design and conduct of the study; in the collection, management, analysis, and interpretation of the data; or in the preparation, review, and approval of the manuscript.

PII: S0002-9149(08)00054-4

doi:10.1016/j.amjcard.2007.12.029

American Journal of Cardiology
Volume 101, Issue 9 , Pages 1281-1284, 1 May 2008